Source: MarketScreener

Microport: MicroPort Scientific : 2020 INTERIM REPORT

(marketscreener.com) the world's first thoracic branch stent maintained rapid growth with its outstanding clinical performance and application in more than 400 hospitals across China. The MinosTM Abdominal Aortic Aneurysm and Delivery System steadily accelerated the process of bidding and entering hospitals since its launch....https://www.marketscreener.com/quote/stock/MICROPORT-SCIENTIFIC-CORP-6727702/news/MicroPort-Scientific-2020-INTERIM-REPORT-31320059/?utm_medium=RSS&utm_content=20200918

Read full article »
Annual Revenue
$500M-1.0B
Employees
5.0-10K
Zhaohua Chang's photo - CEO of MicroPort Scientific Corporation

CEO

Zhaohua Chang

CEO Approval Rating

68/100

Read more